Mikio Igawa
- Urology top 1%
- Urological Disorders and Treatments 24
- Cancer Research top 5%
-
- Prostate Cancer Treatment and Research 26
- Prostate Cancer Diagnosis and Treatment 20
- Renal cell carcinoma treatment 12
- Molecular Biology top 5%
- Epigenetics and DNA Methylation 22
- Cancer-related gene regulation 16
- Oncology top 5%
-
- Bladder and Urothelial Cancer Treatments 40
- Urinary and Genital Oncology Studies 23
- Co-authors
- Hiroaki ShiinaShinji UrakamiRajvir DahiyaKazushi ShigenoNobuyuki KikunoHideki EnokidaTatsuaki YonedaYuichiro Tanaka
- Journals
- The Journal of Urology (36 papers)British Journal of Urology (10 papers)International Journal of Urology (9 papers)
- Partner nations
- JapanUnited StatesSweden
In The Last Decade
Mikio Igawa
164 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 128
- Urology 422
- Cancer Research 520
- Pulmonary and Respiratory Medicine 1.1k
- Molecular Biology 2.2k
- Oncology 691
Countries citing papers authored by Mikio Igawa
This map shows the geographic impact of Mikio Igawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikio Igawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikio Igawa more than expected).
Fields of papers citing papers by Mikio Igawa
This network shows the impact of papers produced by Mikio Igawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikio Igawa. The network helps show where Mikio Igawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mikio Igawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 6 | |
| 2 | 2012 | 13 | |
| 3 | 2012 | 6 | |
| 4 | 2011 | 1 | |
| 5 | 2011 | 6 | |
| 6 | 2011 | 10 | |
| 7 | 2009 | 15 | |
| 8 | 2008 | 14 | |
| 9 | 2007 | 1 | |
| 10 | 2005 | 40 | |
| 11 | 2003 | 13 | |
| 12 | 2000 | 8 | |
| 13 | 1999 | 51 | |
| 14 | 1999 | 1 | |
| 15 | 1996 | 8 | |
| 16 | 1996 | 10 | |
| 17 | 1994 | 1 | |
| 18 | 1994 | 50 | |
| 19 | 1993 | 11 | |
| 20 | M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy for advanced bladder cancer | 1990 | 1 |
About Mikio Igawa
Mikio Igawa is a scholar working on Urology, Pulmonary and Respiratory Medicine and Surgery, having authored 175 papers that have together received 4.1k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (40 papers), Prostate Cancer Treatment and Research (26 papers), Urological Disorders and Treatments (24 papers), Urinary and Genital Oncology Studies (23 papers), Epigenetics and DNA Methylation (22 papers), Prostate Cancer Diagnosis and Treatment (20 papers), Cancer-related gene regulation (16 papers) and Renal cell carcinoma treatment (12 papers). The work is most often cited by research in Urology (422 citations), Cancer Research (520 citations) and Pulmonary and Respiratory Medicine (1.1k citations). Mikio Igawa has collaborated with scholars based in Japan, United States and Sweden. Frequent co-authors include Hiroaki Shiina, Shinji Urakami, Rajvir Dahiya, Kazushi Shigeno, Nobuyuki Kikuno, Hideki Enokida, Tatsuaki Yoneda, Yuichiro Tanaka, Toshifumi Kawakami and Masaharu Terashima. Their work appears in journals such as The Journal of Urology, British Journal of Urology, International Journal of Urology, Clinical Cancer Research and European Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.